On the stock market since 2016, it operates in the world of health and science. It has 402 employees. Now — the numbers.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
It pays out $1.00 per share each year — regular cash for whoever holds the stock.
The price action doesn’t yet back an upward turn. Council score: 0/10.
On our five-subject report card, SMDCF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: SMDCF is a high-risk stock — not yet profitable, and its future rides on its product catching on.